Serotype 6C invasive pneumococcal disease in Indigenous people in north Queensland

Authors

  • Jeffrey N Hanna 1. Cairns Public Health Unit, Tropical Regional Services, Division of the Chief Health Officer, Queensland Health, Cairns Queensland 2. Townsville Public Health Unit, Tropical Regional Services, Division of the Chief Health Officer, Queensland Health, Townsville Queensland 3. Public Health Microbiology, Queensland Health Forensic and Scientific Services, Coopers Plains Queensland
  • Jan L Humphreys Townsville Public Health Unit, Tropical Regional Services, Division of the Chief Health Officer, Queensland Health, Townsville Queensland
  • Amy Jennison Public Health Microbiology, Queensland Health Forensic and Scientific Services, Coopers Plains Queensland
  • Megan Penny Public Health Microbiology, Queensland Health Forensic and Scientific Services, Coopers Plains Queensland
  • Helen V Smith Public Health Microbiology, Queensland Health Forensic and Scientific Services, Coopers Plains Queensland

DOI:

https://doi.org/10.33321/cdi.2010.34.17

Keywords:

Streptococcus pneumoniae, Indigenous health, Queensland

Abstract

This report discusses cases of a previously unrecognised serotype of Streptococcus pneumoniae, designated as serotype 6C, which was first described in 2007.

Downloads

Download data is not yet available.

References

Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007;45(4):1225–1233.

Park IH, Park S, Hollingshead SK, Nahm MH. Genetic basis for the new pneumococcal serotype, 6C. Infect Immun 2007;75(9):4482–4489.

Hanna JN, Humphreys JL, Murphy DM. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005–2007. Med J Aust 2008;189(1):43–46.

Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006;368(9546):1495–1502.

Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 2007;196(9):1346–1354.

Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 2008;198(12):1818–1822.

Nahm MH, Lin J, Finkelstein JA, Pelton SI. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of the pneumococcal conjugate vaccine. J Infect Dis 2009;199(3):320–325.

da Gloria Caravalho M, Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA, Keys LE, et al. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 2009;47(3):554–559.

Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children – Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59(9):258–261.

Downloads

Published

01/06/10

How to Cite

Hanna, Jeffrey N, Jan L Humphreys, Amy Jennison, Megan Penny, and Helen V Smith. 2010. “Serotype 6C Invasive Pneumococcal Disease in Indigenous People in North Queensland”. Communicable Diseases Intelligence 34 (June):122-23. https://doi.org/10.33321/cdi.2010.34.17.

Issue

Vol. 34 (2010)

Section

Short report

Categories

License

Copyright (c) 2010 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>